Zhang Xiao-Yi, Luo Shao-Bo, Zhang Jin-Ying, Meng Zhe-Cheng
Department of Urology, General Hospital of the PLA Rocket Force, Beijing 100088, China.
Department of Andrology, Guang'anmen Hospital (South Section), Chinese Academy of Chinese Medical Sciences, Beijing 102638, China.
Zhonghua Nan Ke Xue. 2017 May;23(5):464-467.
To investigate the short- and long-term effects of triple acupuncture at the Qugu acupoint as an adjunctive therapy on type-Ⅲ chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS).
We equally randomized 90 CP/CPPS patients into a control and a treatment group, both treated with Levofloxacin Mesylate Tablets (0.5 g, tid) + Terazosin Hydrochloride Capsules (2 mg qd) for 4 weeks, while the latter group by triple acupuncture at the Qugu acupoint as an adjunctive therapy twice a week at the same time. Then, we followed up all the patients for 4 weeks, recorded the cases, time and rate of recurrence, obtained the scores in National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), quality of life (QoL) and Zung Depression Scale (ZDS), and compared them between the two groups of patients.
Compared with the controls, the patients of the treatment group showed significantly decreased NIH-CPSI scores in pain (8.6 ± 2.12 vs 6.2 ± 2.25, P <0.05), micturition (5.8 ± 1.22 vs 3.1 ± 1.10, P <0.05), and QoL (6.0 ± 1.33 vs 3.4 ± 1.71, P <0.05) and ZDS score as well (43.9 ± 4.53 vs 33.6 ± 3.20, P <0.01). The recurrence rate was markedly lower while the recurrence time remarkably longer in the treatment than in the control group (15.56 vs 35.56% and ［20.0 ± 2.72］ vs ［12.5 ± 3.47］ d, P <0.05).
As an adjunctive therapy, triple acupuncture at the Qugu acupoint can evidently ameliorate the clinical symptoms, enhance the curative effect of antibacterials, reduce the recurrence rate, and prolong the recurrence time in the treatment of CP/CPPS.
探讨曲骨穴三联针刺辅助治疗Ⅲ型慢性前列腺炎/慢性盆腔疼痛综合征（CP/CPPS）的近期及远期疗效。
将90例CP/CPPS患者随机分为对照组和治疗组，两组均口服甲磺酸左氧氟沙星片（0.5 g，每日3次）+盐酸特拉唑嗪胶囊（2 mg，每日1次），疗程4周，治疗组在此基础上加用曲骨穴三联针刺辅助治疗，每周2次。随访4周，记录复发例数、复发时间及复发率，采用美国国立卫生研究院慢性前列腺炎症状指数（NIH-CPSI）、生活质量（QoL）及zung抑郁自评量表（ZDS）进行评分，并比较两组患者上述指标的差异。
治疗组患者疼痛（8.6±2.12比6.2±2.25，P<0.05）、排尿症状（5.8±1.22比3.1±1.10，P<0.05）、生活质量（6.0±1.33比3.4±1.71，P<0.05）及ZDS评分（43.9±4.53比33.6±3.20，P<0.01）均较对照组显著降低。治疗组复发率明显低于对照组（15.56%比35.56%），复发时间明显长于对照组（[20.0±2.72]天比[12.5±3.47]天，P<0.05）。
曲骨穴三联针刺辅助治疗CP/CPPS能明显改善临床症状，提高抗菌药物疗效，降低复发率，延长复发时间。
